Abstract

This study was conducted to determine if oral administration of the novel herbal medicine, KIOM-MA, and its Lactobacillus acidophilus-fermented product, KIOM-MA128, has therapeutic properties for the treatment of atopic dermatitis (AD). Using AD-induced BALB/c mice by Ovalbumin and aluminum hydroxide, the effectiveness of KIOM-MA and KIOM-MA128 on AD was evaluated. Oral administration of KIOM-MA and KIOM-MA128 reduced major clinical signs of AD including erythema/darkening, edema/papulation, excoriations, lichenification/prurigo, and dryness. Interestingly, KIOM-MA128 more significantly improved AD-related symptoms including decrease of IgE level in the plasma as well as reduction of scratching behavior, skin severity in the AD BALB/c model. HPLC analysis showed the significant changes in the constituent patterns between KIOM-MA and KIOM-MA128. Our results suggest that both KIOM-MA and KIOM-MA128 have potential for therapeutic reagent for the treatment of AD, and further, the efficacy is significantly enhanced by L. acidophilus fermentation via increases in its indicator molecule.

Highlights

  • Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers that are innocuous to normal nonatopic individuals [1]

  • We report that newly formulated herbal medicine Korea Institute of Oriental Medicine (KIOM)-MA possesses strong antiatopic activity and KIOM-MA128, fermented form by L. acidophilus, exerts more potent inhibitory effect on AD

  • Six maker compounds of KIOMMA and KIOM-MA128 liquiritin, nodakenin, icariin, glycyrrhizin

Read more

Summary

Introduction

Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers that are innocuous to normal nonatopic individuals [1]. Several studies have suggested that atopic dermatitis is the cutaneous manifestation of a systemic disorder that gives rise to asthma, food allergy, and allergic rhinitis [3, 4]. These conditions are all characterized by elevated serum IgE levels and peripheral eosinophilia [5]. There has been increased interest in the use of traditional herbal medicine to develop new therapeutic agents without a steroid for AD treatment [10]. Recent studies have suggested that fermentation of herbal extracts may affect the therapeutic potential due to their increased absorptive effect [17]. We report that newly formulated herbal medicine KIOM-MA possesses strong antiatopic activity and KIOM-MA128, fermented form by L. acidophilus, exerts more potent inhibitory effect on AD

Materials and Methods
Results
The Effect of KIOM-MA and KIOM-MA128 on Clinical
The Effect of KIOM-MA and KIOM-MA128 on Scratching
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.